Thromboprophylaxis for women undergoing caesarean section

Thromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI c...

Full description

Saved in:
Bibliographic Details
Published in:Irish medical journal 2012-02, Vol.105 (2), p.56-57
Main Authors: Kennedy, C, O'Dwyer, V, O'Kelly, S, Farah, N, Kennelly, M, Turner, M J
Format: Article
Language:English
Subjects:
Cesarean Section
Female
Fibrinolytic Agents - administration & dosage
Guideline Adherence
Heparin, Low-Molecular-Weight - administration & dosage
Humans
Prospective Studies
Venous Thrombosis - prevention & control
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI calculated at the first antenatal visit. Of the 284 women, 68 (24%) had a CS and all received tinzaparin. Of the 68, however, 94% received a dose lower than recommended. Compliance with prophylaxis was complete but compliance with the recommended dosage was suboptimal, which may result in venous thromboembolism after CS despite thromboprophylaxis.
ISSN:0332-3102